4D Advisors LLC Makes New $1.09 Million Investment in American Well Co. (NYSE:AMWL)

4D Advisors LLC purchased a new position in American Well Co. (NYSE:AMWL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 150,000 shares of the company's stock, valued at approximately $1,088,000. 4D Advisors LLC owned about 0.98% of American Well at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Senvest Management LLC boosted its holdings in shares of American Well by 3.9% during the 4th quarter. Senvest Management LLC now owns 1,300,611 shares of the company's stock valued at $9,429,000 after acquiring an additional 48,800 shares during the last quarter. Geode Capital Management LLC lifted its position in American Well by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 147,925 shares of the company's stock valued at $1,073,000 after purchasing an additional 922 shares during the period. Takeda Pharmaceutical Co. Ltd. purchased a new stake in American Well in the fourth quarter worth approximately $564,000. Northern Trust Corp grew its position in American Well by 7.4% in the 4th quarter. Northern Trust Corp now owns 29,021 shares of the company's stock worth $210,000 after purchasing an additional 1,992 shares during the period. Finally, Norges Bank purchased a new stake in American Well during the 4th quarter valued at $204,000. Institutional investors own 56.05% of the company's stock.

American Well Price Performance

Shares of NYSE:AMWL traded down $0.06 during mid-day trading on Wednesday, reaching $6.73. 12,884 shares of the company traded hands, compared to its average volume of 90,948. American Well Co. has a 52 week low of $5.00 and a 52 week high of $12.95. The firm has a market cap of $105.06 million, a PE ratio of -0.48 and a beta of 1.22. The company's 50 day moving average price is $7.58 and its 200-day moving average price is $8.78.

American Well (NYSE:AMWL - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported ($1.73) EPS for the quarter, topping analysts' consensus estimates of ($3.09) by $1.36. American Well had a negative return on equity of 56.73% and a negative net margin of 81.83%. The company had revenue of $66.83 million for the quarter, compared to analysts' expectations of $60.15 million. On average, research analysts predict that American Well Co. will post -9.34 earnings per share for the current fiscal year.

Insider Buying and Selling at American Well

In related news, insider Phyllis Gotlib sold 4,781 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $8.80, for a total value of $42,072.80. Following the sale, the insider now directly owns 147,998 shares in the company, valued at approximately $1,302,382.40. The trade was a 3.13 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 12.80% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Stifel Nicolaus cut their price objective on American Well from $10.00 to $8.00 and set a "hold" rating for the company in a report on Friday, May 2nd. Needham & Company LLC restated a "hold" rating on shares of American Well in a research note on Friday, May 2nd. Wells Fargo & Company upgraded shares of American Well from an "equal weight" rating to an "overweight" rating and set a $15.00 price objective on the stock in a research note on Monday, January 13th. Finally, Truist Financial cut their target price on shares of American Well from $12.00 to $7.50 and set a "hold" rating for the company in a research report on Thursday, April 10th. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $10.60.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.